Susquehanna International Group, LLP Summit Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$16.64 - $36.7 $8.39 Million - $18.5 Million	504,400 Added 87.75%	1,079,200 $23 Million
Q1 2025 May 14, 2025	BUY	$16.65 - $23.76 $3.03 Million - $4.32 Million	181,700 Added 46.22%	574,800 $11.1 Million
Q4 2024 Feb 14, 2025	SELL	$17.52 - $23.46 $1.61 Million - $2.16 Million	-92,100 Reduced 18.98%	393,100 $7.02 Million
Q3 2024 Nov 14, 2024	BUY	$6.89 - $31.93 $1.08 Million - $5.01 Million	157,000 Added 47.84%	485,200 $10.6 Million
Q2 2024 Aug 15, 2024	BUY	$2.39 - $10.92 $594,393 - $2.72 Million	248,700 Added 312.83%	328,200 $2.56 Million
Q1 2024 May 07, 2024	BUY	$2.55 - $5.07 $82,620 - $164,268	32,400 Added 68.79%	79,500 $329,000
Q4 2023 Feb 14, 2024	SELL	$1.67 - $2.83 $893,617 - $1.51 Million	-535,100 Reduced 91.91%	47,100 $122,000
Q3 2023 Nov 14, 2023	BUY	$1.54 - $2.42 $803,726 - $1.26 Million	521,900 Added 865.51%	582,200 $1.09 Million
Q2 2023 Aug 11, 2023	SELL	$1.32 - $2.81 $134,244 - $285,777	-101,700 Reduced 62.78%	60,300 $151,000
Q1 2023 May 16, 2023	SELL	$1.38 - $5.41 $561,522 - $2.2 Million	-406,900 Reduced 71.52%	162,000 $283,000
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $386,852 - $3.02 Million	568,900 New	568,900 $2.42 Million
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $48,600 - $83,835	-24,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.45 - $5.64 $105,595 - $243,084	-43,100 Reduced 63.95%	24,300 $65,000
Q3 2021 Nov 15, 2021	SELL	$4.83 - $8.27 $192,717 - $329,973	-39,900 Reduced 37.19%	67,400 $338,000
Q2 2021 Aug 11, 2021	BUY	$5.15 - $8.46 $552,595 - $907,758	107,300 New	107,300 $800,000

Others Institutions Holding SMMT

# of Institutions

263

Shares Held

90.3M

Call Options Held

4.71M

Put Options Held

3.17M

Baker Bros. Advisors LP New York, NY

33.7M
Shares

$720 Million
7.27% of portfolio
Vanguard Group Inc Valley Forge, PA

8.67M
Shares

$185 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.9M
Shares

$169 Million
0.0% of portfolio
State Street Corp Boston, MA

4.02M
Shares

$85.8 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.91M
Shares

$83.4 Million
0.01% of portfolio

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.3B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account